Next Article in Journal
Can the Discovery of High-Impact Diagnostics Be Improved by Matching the Sampling Rate of Clinical Diagnostics to the Frequency Domain of Diagnostic Information?
Next Article in Special Issue
External Lymphatic Fistula After Radical Surgery for Colorectal Cancer: A Case Series
Previous Article in Journal
Application and Validation of a transRADial Access Score (RAD-Access) in Patient Selection for Safe Radial Access in Liver Cancer Intra-Arterial Procedures
Previous Article in Special Issue
Assessing Surgical Approaches and Postoperative Complications for Thoracic Schwannomas: A Multicenter Retrospective Observational Analysis of 106 Cases
 
 
Review
Peer-Review Record

Uncertain Resection in Lung Cancer: A Comprehensive Review of the International Association for the Study of Lung Cancer Classification

Cancers 2025, 17(9), 1386; https://doi.org/10.3390/cancers17091386
by Xavier Cansouline 1,2,*, Abdelhakim Elmraki 1, Béatrice Lipan 1, Damien Sizaret 3, Mathieu Sordet 4, Anne Tallet 3, Christophe Vandier 2, Delphine Carmier 5, Myriam Ammi 6 and Antoine Legras 1,2
Reviewer 1:
Reviewer 2:
Reviewer 3:
Cancers 2025, 17(9), 1386; https://doi.org/10.3390/cancers17091386
Submission received: 17 March 2025 / Revised: 13 April 2025 / Accepted: 17 April 2025 / Published: 22 April 2025

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

The authors analyse the data from various cancer consortium and present the analyzed results and present a schematic evaluation and prospective solutions. However the data is too much heavy in table format and not in figures. In order to present it in journal for wider audience i would suggest the authors present the data in figure format and also keep the language simple for non-specialist audience. 

Author Response

Dear reviewer, Thank you for your comments:

the data is too much heavy in table format and not in figures. In order to present it in journal for wider audience i would suggest the authors present the data in figure format and also keep the language simple for non-specialist audience

We added two figures in addition to tables 1 and 2 for more clarity and simplicty. Some points were rewritten, especially objective to be easier to understand.

Reviewer 2 Report

Comments and Suggestions for Authors
  • It is good to add numerical results in the abstract. (either in results or conclusion with the abstract)
  • The authors should write their aim of the review at the end of the introduction and include a graphical abstract.
  • The results are confusing. The authors should add some figures to accomplish the text.
  • The main question/problem I have regarding this manuscript is a novelty. The authors summarize some research papers (pages 7-13) to answer what problem.

Author Response

Dear reviewer, Thank you for your comments:

  • It is good to add numerical results in the abstract. (either in results or conclusion with the abstract)
    • As it is a review and not a meta analysis we have no original numerical to share. Nevertheless we slightly enhanced our abstract.
  • The authors should write their aim of the review at the end of the introduction and include a graphical abstract.
    • We rewrote our objective more explicitly. Graphical abstract was already providen but was increased.
  • The results are confusing. The authors should add some figures to accomplish the text.
    • We added two figure in addition of table 1 and 2.
  • The main question/problem I have regarding this manuscript is a novelty. The authors summarize some research papers (pages 7-13) to answer what problem.
    • Objective was rewritten in both abstract and introduction.

Reviewer 3 Report

Comments and Suggestions for Authors

This review article covers important aspects of future directions and relevance of uncertain resection in lung cancer as a novel strategy to increase patient survival.

This specific strategies compiled in this review article are designed to develop reclassification of lung cancer to help to discriminate patients with poor prognosis and better understand the relevance of the IASLC classification.

            The compiled data are supported with informative and important figure and 3 tables. The article concludes with 107 very recent literature references. This consolidated study constitutes crucially important developments, which were never ever reported and in such systematic and specific order and sequences, therefore deserve publication as soon as possible.

The following suggested changes and recommendations should be introduced before the publication of the manuscript:

  • Page 5, table 1. Please switch the order of column (Design) with (Patients) column as          first. That would enhance the value of the article by validating the number of                        patients and explore additional citation sequences to benefit the authors.
  • Page 15, line 522-3. I propose that the text should be in “bold” because if this unique importance highlighting eligibility/non-eligibility for minimal dissection.       
  • Page 15, Line 527. Conclusions. This section should be expanded. In its present format, the authors do not fully describe the desired/anticipated prospects of several adjuvant therapies approved by FDA. Authors should also include comparative data available in the literature regarding existing clinical studies demonstrating the high prognostic value of personalized and more effective use and applications depending on category of cancer and number of patients.

The manuscript is of good quality, well-written, and meets the standard for articles published in Cancers. I recommend it for publication after the correction of these minor suggested changes.

Author Response

Dear reviewer,

Thank you for your comments:

  • Page 5, table 1. Please switch the order of column (Design) with (Patients) column as first. That would enhance the value of the article by validating the number of patients and explore additional citation sequences to benefit the authors.
    • Columns switched
  • Page 15, line 522-3. I propose that the text should be in “bold” because if this unique importance highlighting eligibility/non-eligibility for minimal dissection.       
    • Text is now bold
  • Page 15, Line 527. Conclusions. This section should be expanded. In its present format, the authors do not fully describe the desired/anticipated prospects of several adjuvant therapies approved by FDA. Authors should also include comparative data available in the literature regarding existing clinical studies demonstrating the high prognostic value of personalized and more effective use and applications depending on category of cancer and number of patients.
    • We added a short paragraph about the potential of personalized adjuvant treatments, thank you for this suggestion

Following other reviewers advice, we reformulated few sentences to make objective of the study more understable. We also added 2 figures in addition to tables 1 and 2 to make them more easy to read. Graphical abstract was simplified.

Round 2

Reviewer 2 Report

Comments and Suggestions for Authors

The authors partially improved their manuscript. They have to add numerical results in the abstract part and add a graphical abstract at the end of the introduction. 

Author Response

Dear reviewer, 

Thank you for your comments. We added the graphical abstrac below the introduction. We also added numerical in the abstract but as we did not perform a meta analysis we do not have much original statistics to share.

Author Response File: Author Response.docx

Round 3

Reviewer 2 Report

Comments and Suggestions for Authors

The authors provided the requested improvement and now it is acceptable. 

Back to TopTop